Article Text

Download PDFPDF

CASE REPORT
Burn aggravated infected wart in a patient with type 2 diabetes: a medical challenge
  1. Tahseen Ahmed Khan1,
  2. Mahmood Sheikh2,
  3. Iqbal Azher2,
  4. Abdul Khaliq Sheikh3
  1. 1 Department of Diabetology, Indus Hospital, Karachi, Pakistan
  2. 2 Department of Pharmacognosy, University of Karachi, Karachi, Pakistan
  3. 3 Department of Pharmaceutics, Hamdard University, Karachi, Pakistan
  1. Correspondence to Dr Tahseen Ahmed Khan, tahseen.ahmed{at}hotmail.com

Summary

An infectious wart of foot in a patient with diabetics is a medical challenge, and it gets worse when aggravated with burns. We present a case of a 67-year-old Pakistani man, diabetic for 20 years presented at our healthcare centre. While awaiting his culture sensitivity report, he was prescribed an empiric antibiotic therapy. Patient then travelled to Saudi Arabia for pilgrimage 3 days later with growth of Staphylococcus aureus and Proteus species in culture and sensitivity report; during his travel, he walked barefoot and the infected wart aggravated with severe burn. Patient continued empiric treatment for 14 days. On his arrival, infected wart worsened with dead burnt skin, heavy purulent discharge on plantar region. X-rays revealed marked arthritic changes. Cefepime 500 mg three times a day intravenously was initiated following wound debridement. Patient was switched to moxifloxacin 400 mg once daily postoperatively for 7 days until completely healed.

  • diabetes
  • dermatological
  • wound care
  • drugs: infectious diseases
  • infections

This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors TAK contributed to the concept, design, planning and conduct of this case study. MS contributed as a study coordinator for this case study. IA contributed for the analysis of data and its interpretation. AKS contributed for writing the manuscript.

  • Funding This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.